LINC02192

Across TCGA pan-cancer cohorts, LINC02192 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC02192 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC02192 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02192 expression acts as an unfavorable survival marker, although some lineages such as PAAD and MESO show a favorable association.

BRCA, PAAD, and HNSC are the cancer types where LINC02192 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	III,IV	0.751	0.865	.012	30	view →
PAAD	DFS	Tertile	All	0.612	0.446	.021	27	view →
HNSC	OS	Tertile	III,IV	0.403	0.712	.008	27	view →
ACC	OS	Quartile	All	0.313	0.719	.005	20	view →
MESO	OS	Tertile	II,III,IV	1.000	0.232	.018	18	view →
THYM	OS	Tertile	All	0.886	0.982	.018	18	view →
CHOL	OS	Tertile	All	0.543	0.830	.028	18	view →
TGCT	DFS	Median	All	0.900	0.703	.002	18	view →
UCEC	DFS	Tertile	All	0.850	0.903	.007	18	view →
KIRP	DFS	Tertile	II,III,IV	0.140	0.668	.048	9	view →
PRAD	DFS	Tertile	All	0.825	0.898	.027	6	view →
KICH	DFS	Quartile	III,IV	0.529	0.811	.033	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC02192–BRCA (OS)

Open the BRCA breakdown →